Enfuvirtide (T-20, Fuzeon): News
- Important Changes to Fuzeon Product Labeling (January 31, 2007)
From U.S. Food and Drug Administration - Fuzeon Accelerated Simultaneous Access Program (Fuzeon ASAP) (September 2004)
A new program provides "immediate" supplies of T-20 to patients who are prescribed the drug together with another investigational drug.
From Roche Laboratories, Inc. and Trimeris, Inc. - Fuzeon Fizzles: Bungled T-20 Launch Claims Its First Casualties, as Losses Spread (March 2004)
In TAGline, from Treatment Action Group - Antiretroviral Drug Fuzeon Sales Slower Than Expected; High Cost, Injection Delivery Method Cited (September 16, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Roche Able to Produce More Fuzeon Than Expected (July 15, 2003)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Washington, D.C. Delays Approving City's ADAP Coverage for T-20 (July 2, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Most U.S. Insurers Will Cover Cost of T-20 (May 15, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - ConFuzeon Reigns (April 2003)
More details of Roche's T-20 distribution plan.
In GMHC Treatment Issues, from Gay Men's Health Crisis - U.S. Price for AIDS Drug: $20,000 (March 24, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Roche/Trimeris to Help Patients Get Fuzeon (March 17, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - T-20: Most Expensive AIDS Drug Ever at $25,000 Per Year? (March 14, 2003)
In AIDS Treatment News, from AIDS Treatment News - Fuzeon Brand Enfuvirtide (T-20): Breaking Barriers or Breaking the Bank? (March 7, 2003)
A position paper from a number of prominent AIDS organizations.
In TAGline, from Treatment Action Group - Food and Drug Administration Grants Priority Status for HIV Drug Fuzeon (October 14, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Treatment Alert: New Expanded Access Program for T-20 (Fall 2002)
To read PDF, click here
In STEP Perspective, from Seattle Treatment Education Project - T-20 Expanded Access Limps Forward (July/August 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis - T-20, Trimeris/Roche Open Label (January/February 2002)
In Positively Aware, from Test Positive Aware Network
Clinical Management
Clinical Management
  |